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Letters
these. I can envisage a surveillance model 
in which the veterinary profession and 
government would be partners in species 
and expert groups that bring together 
monitored data and the intelligence for 
interpretation at the population level. 
This would collectively provide better 
identification and understanding of all 
threats and issues and their impact and will 
inform management by whoever is best 
placed to do so.
Nigel Gibbens, Chief Veterinary Officer, 
Defra, Nobel House, Smith Square, London 
SW1P 3JR
e-mail: nigel.gibbens@defra.gsi.gov.uk
doi: 10.1136/vr.f971
EMERGING DISEASES
Testing for 
Schmallenberg virus
AS a screening method for detecting 
herd-level exposure to Schmallenberg virus 
(SBV), the bulk milk SBV antibody ELISA 
offered by Biobest Laboratories has proved 
popular. Results from this test suggest that 
the majority of herds in England and Wales 
have been exposed to SBV (Humphries and 
Burr 2012). Indeed, veterinary practices 
local to us have stopped routinely testing 
bulk milk tank samples as all herds tested 
have been positive. However, this testing 
method does not give an indication of the 
numbers of animals within a herd that have 
been exposed to the virus.
In this context, we would like to 
highlight results from the University of 
Nottingham’s 200-head indoor dairy herd. 
This herd had a positive bulk milk tank 
test but only a 25 per cent seroprevalence 
(5/20 animals tested) for SBV. In contrast, 
seroprevalence in another herd, housed 
outdoors during the summer, six miles 
from the university’s herd, had 76 per cent 
seroprevalence (13/17 animals tested).
The seroprevalence rates for the outdoor 
herd are consistent with those reported 
in cattle in Belgium (86 per cent) and the 
Netherlands (70 to 100 per cent) near the 
epicentre of the SBV outbreak in 2011/12 
(Elbers and others 2012, Meroc and others 
2012). The results for the indoor herd 
suggest that the majority of individuals 
within the herd will remain susceptible 
to SBV infection during the 2013 midge 
season. This low seroprevalence may well 
be due to low midge exposure in indoor 
environments. This is also suggested by 
other reports of herds housed indoors with 
negative SBV bulk milk tank tests in regions 
with high SBV exposure rates (Case 2013) 
as well as suggestions made in the Belgian 
study that indoor housing of youngstock 
may be associated with the significantly 
lower seroprevalence seen in animals under 
two years of age.
With the likely introduction of a 
vaccine against SBV in 2013, veterinarians 
and farm managers will be weighing the 
costs and benefits of vaccinating herds 
and flocks. Knowledge of a herd’s existing 
seroprevalence will be a critical factor in this 
analysis. Garnering this information may, 
however, be restricted by the cost of testing 
and there is a need to develop cheap pen-side 
tests for SBV that can be used to help make 
vaccination decisions for individual farms.
Rachael Tarlinton, Janet Daly, School of 
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of Nottingham, Sutton Bonington Campus, 
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SURVEILLANCE
Future of surveillance
I WELCOME the letter from Richard 
Sibley and Peter Orpin (VR, January 26, 
2013, vol 172, p 108), which further raises 
the future of surveillance and the benefits 
it provides. The letter provides real-life 
examples of how data gathered direct from 
farmers and private veterinary surgeons 
can be of benefit in understanding a 
national and regional picture of production 
and disease trends and their real-time 
impacts. I support their assertion that 
surveillance needs to consider wider sources 
of information than just postmortem 
examinations and lab diagnostics. 
The current AHVLA consultation on 
surveillance seeks to find ways to improve 
the way we all do surveillance so that we 
have a better assessment and understanding 
of threats and can effectively manage these. 
This needs to be done as a partnership 
between government and industry, in 
which we both contribute and can both 
benefit.
Government’s need from surveillance is 
the early detection of new and re-emerging 
disease. Indeed, for Schmallenberg virus 
(SBV) this was very effective. Information 
from our continental neighbours 
alerted us to this new threat, which 
was then detected through laboratory 
surveillance in the south-east of England, 
probably very shortly after incursion. 
Additional investigative surveillance was 
commissioned to ensure that information 
was available to farmers and their advisers 
to make informed choices for their 
businesses. We now know that the virus 
has spread across England and it is no 
surprise that antibodies can be detected in 
many herds. However, I don’t think we can 
assume a direct relationship between the 
spread of SBV and the production losses 
described. I would like to caution against 
ascribing causality without investigation 
when we know that these clinical signs are 
not specific to SBV and can be caused by a 
large variety of diseases and other factors.
As for many endemic diseases, 
there comes a point when government 
can no longer add value to control or 
management. Our purpose is not to directly 
be a data collator or to monitor all data 
on livestock ourselves. As Mr Sibley and 
Mr Oprin describe, there are a number of 
tools available that help farmers and vets 
identify health and welfare risks to specific 
businesses and there are recognised and 
effective mitigating actions for most of 
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